Entities / Company
Compugen Ltd..
publicly traded Israeli drug discovery company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Compugen Ltd. this week
News at the entities that move Compugen Ltd. most-
AstraZeneca StructuralAstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.Moves Compugen Ltd.
-
Gilead Sciences TransactionalAmgen and Gilead Sciences are two companies that compete within the biotech industry.Moves Compugen Ltd.
-
New York City Shared contextDSM-Firmenich opens a new flagship location in Chelsea, NYC, while Housing Works participates in an Open Air event.Moves Compugen Ltd.
Connections
The 5 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Structural
Compugen licenses technology and antibodies to AstraZeneca, enabling the development of the drug Rilvegostomig.
-
Gilead Sciences Transactional
Compugen licensed the drug candidate GS-0321 to Gilead for development following a partnership agreement.
-
Gilead Transactional
Compugen and Gilead engaged in multiple licensing agreements for the GS-0321 antibody.
-
Gilead Transactional
Gilead entered into a licensing agreement with Compugen Ltd. for the technology GS-0321.
-
New York City Shared context
Compugen Ltd. operates within the geographical and professional context of New York City.